664 related articles for article (PubMed ID: 33970745)
21. Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
Gao Y; Chen Y; Liu M; Niu M; Song Z; Yan M; Tian J
Epidemiol Infect; 2021 Feb; 149():e66. PubMed ID: 33583450
[TBL] [Abstract][Full Text] [Related]
22. A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
Grover A; Oberoi M
Eur Heart J Cardiovasc Pharmacother; 2021 Mar; 7(2):148-157. PubMed ID: 32542337
[TBL] [Abstract][Full Text] [Related]
23. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19.
Yekedüz E; Utkan G; Ürün Y
Eur J Cancer; 2020 Dec; 141():92-104. PubMed ID: 33130550
[TBL] [Abstract][Full Text] [Related]
24. Association of active immunotherapy with outcomes in cancer patients with COVID-19: a systematic review and meta-analysis.
Cao C; Gan X; Hu X; Su Y; Zhang Y; Peng X
Aging (Albany NY); 2022 Mar; 14(5):2062-2080. PubMed ID: 35271463
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 and coagulation dysfunction in adults: A systematic review and meta-analysis.
Lin J; Yan H; Chen H; He C; Lin C; He H; Zhang S; Shi S; Lin K
J Med Virol; 2021 Feb; 93(2):934-944. PubMed ID: 32706426
[TBL] [Abstract][Full Text] [Related]
26. Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis.
Dalia T; Lahan S; Ranka S; Acharya P; Gautam A; Goyal A; Mastoris I; Sauer A; Shah Z
Indian Heart J; 2021; 73(1):91-98. PubMed ID: 33714416
[TBL] [Abstract][Full Text] [Related]
27. Effect of antitumor therapy on cancer patients infected by SARS-CoV-2: A systematic review and meta-analysis.
Li P; Li L; Wang S; Liu Y; Li Z; Xia S
Cancer Med; 2021 Mar; 10(5):1644-1655. PubMed ID: 33547886
[TBL] [Abstract][Full Text] [Related]
28. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis.
Aggarwal G; Cheruiyot I; Aggarwal S; Wong J; Lippi G; Lavie CJ; Henry BM; Sanchis-Gomar F
Curr Probl Cardiol; 2020 Aug; 45(8):100617. PubMed ID: 32402515
[TBL] [Abstract][Full Text] [Related]
29. Obesity in COVID-19: A Systematic Review and Meta-analysis.
Ho JSY; Fernando DI; Chan MY; Sia CH
Ann Acad Med Singap; 2020 Dec; 49(12):996-1008. PubMed ID: 33463658
[TBL] [Abstract][Full Text] [Related]
30. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
31. A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus.
Venkatesulu BP; Chandrasekar VT; Girdhar P; Advani P; Sharma A; Elumalai T; Hsieh CE; Elghazawy HI; Verma V; Krishnan S
JNCI Cancer Spectr; 2021 Apr; 5(2):pkaa102. PubMed ID: 33875976
[TBL] [Abstract][Full Text] [Related]
32. Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis.
Zinellu A; Paliogiannis P; Carru C; Mangoni AA
Int J Infect Dis; 2021 Apr; 105():668-674. PubMed ID: 33737133
[TBL] [Abstract][Full Text] [Related]
33. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
[TBL] [Abstract][Full Text] [Related]
34. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
[TBL] [Abstract][Full Text] [Related]
35. Effect of antiplatelet treatments on patients with COVID-19 infection: A systematic review and meta-analysis.
Wang Y; Ao G; Nasr B; Qi X
Am J Emerg Med; 2021 May; 43():27-30. PubMed ID: 33485124
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
38. Prediabetes and COVID-19 severity, an underestimated risk factor: A systematic review and meta-analysis.
Heidarpour M; Abhari AP; Sadeghpour N; Shafie D; Sarokhani D
Diabetes Metab Syndr; 2021; 15(6):102307. PubMed ID: 34731820
[TBL] [Abstract][Full Text] [Related]
39. Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies.
Liu Y; Lu H; Wang W; Liu Q; Zhu C
Expert Rev Anticancer Ther; 2021 Jan; 21(1):107-119. PubMed ID: 33054414
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review.
Nahshon C; Segev Y; Schmidt M; Bar-Noy T; Ostrovsky L; Lavie O
J Chemother; 2021 Dec; 33(8):528-538. PubMed ID: 33769233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
